BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1004 related articles for article (PubMed ID: 15866577)

  • 1. Soluble human leukocyte antigen G expression in phase I culture media at 46 hours after fertilization predicts pregnancy and implantation from day 3 embryo transfer.
    Sher G; Keskintepe L; Fisch JD; Acacio BA; Ahlering P; Batzofin J; Ginsburg M
    Fertil Steril; 2005 May; 83(5):1410-3. PubMed ID: 15866577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graduated Embryo Score and soluble human leukocyte antigen-G expression improve assisted reproductive technology outcomes and suggest a basis for elective single-embryo transfer.
    Fisch JD; Keskintepe L; Ginsburg M; Adamowicz M; Sher G
    Fertil Steril; 2007 Apr; 87(4):757-63. PubMed ID: 17224145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of early ICSI-derived embryo sHLA-G expression on pregnancy and implantation rates: a prospective study.
    Sher G; Keskintepe L; Batzofin J; Fisch J; Acacio B; Ahlering P; Ginsburg M
    Hum Reprod; 2005 May; 20(5):1359-63. PubMed ID: 15746200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the biochemical marker soluble human leukocyte antigen G on pregnancy outcome in assisted reproductive technology--a multicenter study.
    Kotze D; Kruger TF; Lombard C; Padayachee T; Keskintepe L; Sher G
    Fertil Steril; 2013 Nov; 100(5):1303-9. PubMed ID: 23993930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to predict implantation? No correlation between embryonic aneuploidy and soluble human leukocyte antigen G-concentrations.
    Coulam CB; Roussev RG; Lerner S; Zlatopolsky Z; Ilkevitch Y; Tur-Kaspa I
    Fertil Steril; 2009 Jun; 91(6):2408-13. PubMed ID: 19394602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the best time to perform intracytoplasmic sperm injection/embryo transfer cycle after hysteroscopic surgery for an incomplete uterine septum?
    Berkkanoglu M; Isikoglu M; Arici F; Ozgur K
    Fertil Steril; 2008 Dec; 90(6):2112-5. PubMed ID: 18177864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injection of day 2 embryo culture supernatant into the uterine cavity did not improve the pregnancy rate of day 3 embryo transfer in patients who underwent in vitro fertilization-embryo transfer: a randomized clinical trial.
    Zhu W; Li X; Fu Z; Tang Z; Chen X; Zhou Y; Geng Q
    Fertil Steril; 2010 May; 93(7):2216-21. PubMed ID: 19439284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Day 4 versus day 3 embryo transfer: a prospective study of clinical outcomes.
    Pantos K; Makrakis E; Chronopoulou M; Biba M; Perdikaris A; Dafereras A
    Fertil Steril; 2008 Mar; 89(3):573-7. PubMed ID: 17517409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Number of good quality embryos on day 3 is predictive for both pregnancy and implantation rates in in vitro fertilization/intracytoplasmic sperm injection cycles.
    Volpes A; Sammartano F; Coffaro F; Mistretta V; Scaglione P; Allegra A
    Fertil Steril; 2004 Nov; 82(5):1330-6. PubMed ID: 15533355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of sHLA-G in supernatants of individually cultured 46-h embryos: a potentially valuable indicator of 'embryo competency' and IVF outcome.
    Sher G; Keskintepe L; Nouriani M; Roussev R; Batzofin J
    Reprod Biomed Online; 2004 Jul; 9(1):74-8. PubMed ID: 15257824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. sHLA-G production by human IVF embryos: can it be measured reliably?
    Sargent I; Swales A; Ledee N; Kozma N; Tabiasco J; Le Bouteiller P
    J Reprod Immunol; 2007 Oct; 75(2):128-32. PubMed ID: 17482269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryonic soluble HLA-G as a marker of developmental potential in embryos.
    Noci I; Fuzzi B; Rizzo R; Melchiorri L; Criscuoli L; Dabizzi S; Biagiotti R; Pellegrini S; Menicucci A; Baricordi OR
    Hum Reprod; 2005 Jan; 20(1):138-46. PubMed ID: 15498780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer of blastocysts and morulae on day 5.
    Wilson M; Hartke K; Kiehl M; Rodgers J; Brabec C; Lyles R
    Fertil Steril; 2004 Aug; 82(2):327-33. PubMed ID: 15302279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of soluble human leukocyte antigen G and its relationship to embryo development].
    Wang Q; Zhuang GL; Zhou CQ; Li J; Zhong YP; Xu YW; Zhang MF; Deng MF
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):112-5. PubMed ID: 15840292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion of human leukocyte antigen-G by human embryos is associated with a higher in vitro fertilization pregnancy rate.
    Yie SM; Balakier H; Motamedi G; Librach CL
    Fertil Steril; 2005 Jan; 83(1):30-6. PubMed ID: 15652883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble HLA-G is absent from human embryo cultures: a reassessment of sHLA-G detection methods.
    Sageshima N; Shobu T; Awai K; Hashimoto H; Yamashita M; Takeda N; Odawara Y; Nakanishi M; Hatake K; Ishitani A
    J Reprod Immunol; 2007 Aug; 75(1):11-22. PubMed ID: 17485119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Day 2 vs. day 3 embryo transfer after intracytoplasmic sperm injection. A prospective, randomized study.
    Baruffi RL; Mauri AL; Petersen C; Felipe V; Franco Júnior JG
    J Reprod Med; 2003 Aug; 48(8):631-4. PubMed ID: 12971145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blastocyst culture after repeated failure of cleavage-stage embryo transfers: a comparison of day 5 and day 6 transfers.
    Barrenetxea G; López de Larruzea A; Ganzabal T; Jiménez R; Carbonero K; Mandiola M
    Fertil Steril; 2005 Jan; 83(1):49-53. PubMed ID: 15652886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized control comparison study of culture media (HTF versus P1) for human in vitro fertilization.
    Artini PG; Valentino V; Cela V; Cristello F; Vitè A; Genazzani AR
    Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):196-200. PubMed ID: 15358464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble HLA-G and embryo implantation: frequently asked questions.
    Le Bouteiller P; Tabiasco J; Parinaud J
    Gynecol Obstet Invest; 2007; 64(3):134-7. PubMed ID: 17934308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.